Advantage System
Payments companies reported to CMS as associated with Advantage System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Advantage System, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Advantage System
These are the largest totals companies reported as associated with Advantage System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Dara Shalom | Great Neck, NY | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) | $23,887.82 |
| Savitha Krishnan | Mountain View, CA | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) | $18,514.58 |
| Brent Parnell | Birmingham, AL | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) | $13,630.38 |
| David Lovejoy | Macon, GA | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) | $10,750.71 |
| Jannah Thompson | Norton Shores, MI | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) | $10,651.03 |
| Thomas Giudice | West Columbia, SC | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) | $10,396.23 |
| Elizabeth Williams | St. Louis, MO | Urogynecology and Reconstructive Pelvic Surgery (Urology) | $10,011.95 |
| Karyn Eilber | Santa Monica, CA | Urology | $9,636.16 |
| Allison Wyman | Tampa, FL | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) | $9,400.00 |
| Michael Ehlert | Woodbury, MN | Urogynecology and Reconstructive Pelvic Surgery (Urology) | $9,185.00 |
Prescribed Advantage System?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.